2m 2m 2m 2m 2m 2m 2m
RIGEL PHARM (RIGL)
NASDAQ
$40.75-$0.55 (-1.33%)
Price as of Jul 13, 2026 7:01 PM EDT- $787.3MMarket Cap
- 113.44%1-Year Change
- BiotechnologyIndustry
RIGEL PHARM (RIGL)
$40.75-$0.55 (-1.33%)
RIGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $41.30 | ||
Change | -$1.25 (-2.94%) | ||
Open | $41.92 | ||
High | $42.85 | ||
Low | $40.77 | ||
Previous Close | $42.55 | ||
Volume | 430,671 | ||
30-Day Average Volume | 442,563 | ||
1-Week Change | 2.60% | ||
1-Month Change | 25.72% | ||
1-Year Change | 113.44% | ||
3-Year Change | 215.27% | ||
5-Year Change | -0.48% | ||
Fundamentals | |||
Shares Outstanding | 18.5M | ||
Total Assets | $504.6M | ||
Market Cap | $787.3M | ||
Enterprise Value | $807.7M | ||
Period: QTR TTM FY | |||
Revenue | $54.9M | ||
Net Income | $8.7M | ||
Free Cash Flow | -$7.3M | ||
EBIT | $11.9M | ||
EBITDA | $12.5M | ||
Net Working Capital | $144.5M | ||
EPS | $0.44 | ||
Enterprise Value/EBITDA | 65 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 2 | ||
P/E | 97 | ||
PEG | -1 | ||
Price/Free Cash Flow | -108 | ||
Price/Operating Cash Flow | 289 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/27/2024 | ||
Earnings & Revenue